Call for action: Research needs for homeless Canadian women Veterans

Abstract: Veteran homelessness remains a critical issue in Canada, prompting significant government investment and research efforts, particularly concerning the unique challenges faced by women Veterans. The Canadian government has committed over $4 billion since 2015 to address Veteran homelessness, with recent initiatives focusing on gender disparities, including a $1.2 million study on homelessness among women Veterans. Women Veterans are disproportionately affected, making up an estimated 30% of the homeless Veteran population despite representing only 15% of the Canadian Armed Forces. Contributing factors include military sexual trauma, intimate partner violence, mental and physical health conditions, and systemic barriers such as weaker social support and reduced financial stability post-service. Existing research has primarily focused on U.S. Veterans, highlighting the need for Canadian-specific studies on the military-to-civilian transition and homelessness among women Veterans. Addressing these disparities requires more accurate data, increased awareness, and targeted support services to ensure that all Veterans, particularly women, receive the necessary resources for stable and secure housing.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P